A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion

Malignant pleural effusion is a common clinical problem, which often occurs in cases of malignant tumors, especially in lung cancer. In this paper, a pleural effusion detection system based on a microfluidic chip, combined with specific tumor biomarker, hexaminolevulinate (HAL), used to concentrate...

Full description

Bibliographic Details
Main Authors: Yiran Luan, Lei Li, Xiaoyi Xun, Yang Wang, Xinyue Wei, Yuqun Zheng, Zhijuan Fan, Xuguo Sun
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Micromachines
Subjects:
Online Access:https://www.mdpi.com/2072-666X/14/4/771
_version_ 1827744355296739328
author Yiran Luan
Lei Li
Xiaoyi Xun
Yang Wang
Xinyue Wei
Yuqun Zheng
Zhijuan Fan
Xuguo Sun
author_facet Yiran Luan
Lei Li
Xiaoyi Xun
Yang Wang
Xinyue Wei
Yuqun Zheng
Zhijuan Fan
Xuguo Sun
author_sort Yiran Luan
collection DOAJ
description Malignant pleural effusion is a common clinical problem, which often occurs in cases of malignant tumors, especially in lung cancer. In this paper, a pleural effusion detection system based on a microfluidic chip, combined with specific tumor biomarker, hexaminolevulinate (HAL), used to concentrate and identify tumor cells in pleural effusion was reported. The lung adenocarcinoma cell line A549 and mesothelial cell line Met-5A were cultured as the tumor cells and non-tumor cells, respectively. The optimum enrichment effect was achieved in the microfluidic chip when the flow rates of cell suspension and phosphate-buffered saline achieved 2 mL/h and 4 mL/h, respectively. At the optimal flow rate, the proportion of A549 increased from 28.04% to 70.01% due to the concentration effect of the chip, indicating that tumor cells could be enriched by a factor of 2.5 times. In addition, HAL staining results revealed that HAL can be used to identify tumor cells and non-tumor cells in chip and clinical samples. Additionally, the tumor cells obtained from the patients diagnosed with lung cancer were confirmed to be captured in the microfluidic chip, proving the validity of the microfluidic detection system. This study preliminarily demonstrates the microfluidic system is a promising method with which to assist clinical detection in pleural effusion.
first_indexed 2024-03-11T04:44:35Z
format Article
id doaj.art-62e46ceafd154af097a3a6e4d54ac09d
institution Directory Open Access Journal
issn 2072-666X
language English
last_indexed 2024-03-11T04:44:35Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Micromachines
spelling doaj.art-62e46ceafd154af097a3a6e4d54ac09d2023-11-17T20:29:06ZengMDPI AGMicromachines2072-666X2023-03-0114477110.3390/mi14040771A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural EffusionYiran Luan0Lei Li1Xiaoyi Xun2Yang Wang3Xinyue Wei4Yuqun Zheng5Zhijuan Fan6Xuguo Sun7School of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaDepartment of Laboratory, Tianjin Third Central Hospital, Tianjin 300170, ChinaSchool of Medical Laboratory, Tianjin Medical University, Tianjin 300203, ChinaMalignant pleural effusion is a common clinical problem, which often occurs in cases of malignant tumors, especially in lung cancer. In this paper, a pleural effusion detection system based on a microfluidic chip, combined with specific tumor biomarker, hexaminolevulinate (HAL), used to concentrate and identify tumor cells in pleural effusion was reported. The lung adenocarcinoma cell line A549 and mesothelial cell line Met-5A were cultured as the tumor cells and non-tumor cells, respectively. The optimum enrichment effect was achieved in the microfluidic chip when the flow rates of cell suspension and phosphate-buffered saline achieved 2 mL/h and 4 mL/h, respectively. At the optimal flow rate, the proportion of A549 increased from 28.04% to 70.01% due to the concentration effect of the chip, indicating that tumor cells could be enriched by a factor of 2.5 times. In addition, HAL staining results revealed that HAL can be used to identify tumor cells and non-tumor cells in chip and clinical samples. Additionally, the tumor cells obtained from the patients diagnosed with lung cancer were confirmed to be captured in the microfluidic chip, proving the validity of the microfluidic detection system. This study preliminarily demonstrates the microfluidic system is a promising method with which to assist clinical detection in pleural effusion.https://www.mdpi.com/2072-666X/14/4/771microfluidic chiptumor cellspleural effusionhexaminolevulinate
spellingShingle Yiran Luan
Lei Li
Xiaoyi Xun
Yang Wang
Xinyue Wei
Yuqun Zheng
Zhijuan Fan
Xuguo Sun
A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
Micromachines
microfluidic chip
tumor cells
pleural effusion
hexaminolevulinate
title A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
title_full A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
title_fullStr A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
title_full_unstemmed A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
title_short A Microfluidic System for Detecting Tumor Cells Based on Biomarker Hexaminolevulinate (HAL): Applications in Pleural Effusion
title_sort microfluidic system for detecting tumor cells based on biomarker hexaminolevulinate hal applications in pleural effusion
topic microfluidic chip
tumor cells
pleural effusion
hexaminolevulinate
url https://www.mdpi.com/2072-666X/14/4/771
work_keys_str_mv AT yiranluan amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT leili amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xiaoyixun amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT yangwang amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xinyuewei amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT yuqunzheng amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT zhijuanfan amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xuguosun amicrofluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT yiranluan microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT leili microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xiaoyixun microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT yangwang microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xinyuewei microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT yuqunzheng microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT zhijuanfan microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion
AT xuguosun microfluidicsystemfordetectingtumorcellsbasedonbiomarkerhexaminolevulinatehalapplicationsinpleuraleffusion